OmniAb share price logo

OmniAb

NASDAQ: OABI

Small Cap

$4.70

+0.11

(+2.29%)

as on

OmniAb Stock Performance

as on October 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.53
    $4.75
    downward going graph

    3.62%

    Downside

    1.06%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.30
    $5.43
    downward going graph

    72.34%

    Downside

    15.53%

    Upside

    downward going graph

OmniAb share price movements today

Previous Close
$4.59
Open
$4.58
Volume
1.0M
Market Cap
$667.3M
Day's Low - High
$4.53 - $4.75
52 Week Low - High
$1.30 - $5.43

OmniAb Historical Returns

1 Month Return
+ 2.68 %
3 Month Return
+ 116.51 %
1 Year Return
+ 176.51 %
3 Year Return
-6.33 %
5 Year Return
0 %

OmniAb Stock Fundamentals & Key Indicators

Check OmniAb market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$667.3M

EPS (TTM)

-0.36

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-13.14

Industry PE ratio

-7.03

PEG Ratio

-0.25

EBITDA

-20.0M

Revenue (TTM)

38.4M

Profit Margin

50.53%

Return On Equity TTM

-16.59%

OmniAb vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of OmniAb with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
OmniAb image
OmniAb
StrongBuy$667.3MNA-13.1450.53%0.00%
Moderna image
Moderna
Neutral$87.0B-34.65%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$126.7B169.53%28.8586.04%0.00%
Regeneron image
Regeneron
Buy$81.4B43.22%19.0184.86%0.47%

Stock Returns calculator for OmniAb Stock including INR - Dollar returns

The OmniAb stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

OmniAb investment value today

Current value as on today

₹3,05,815

Returns

₹2,05,815

(+205.82%)

Returns from OmniAb Stock

₹1,83,133 (+183.13%)

Dollar Impact

₹22,683 (+22.68%)

Analyst Recommendation on OmniAb Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for OmniAb. Average target price of $8.33

OmniAb Share Price Target

Get share price movements and forecasts by analysts on OmniAb.

What analysts predicted

43.58%UPSIDE

Target Price

$8.33

Current Price

$4.7

Analyzed by

5 Analysts

High

$11

Target

$8.33

Low

$5

OmniAb target price $8.33, a slight upside of 43.58% compared to current price of $4.7. According to 5 analysts rating.

Indian Investors' Interest in OmniAb Stock

Search interest for OmniAb Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

OmniAb Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
3
7
4
10
4
3
2
8
14
13
Gross Profit
3
7
4
10
4
3
-2
0
8
12
Operating Income
-22
-16
-19
-15
-18
-16
-18
-15
-7
-6
EBITDA
-16
-9
-14
-7
-13
-14
-10
-6
0
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
4
6
4
7
4
4
4
7
7
4
Income Before Tax
-21
-15
-19
-15
-18
-15
-15
-14
-7
-6
Income Tax Expense
-2
-1
-2
-2
0
0
1
0
-
0
Net Income
-18
-13
-16
-13
-18
-15
-16
-14
-7
-5
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
93.28%
-109.20%
7.88%
58.33%
95.45%

OmniAb Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
18
23
34
59
34
26
18
Gross Profit
18
23
34
59
34
26
-3
Operating Income
-13
-25
-35
-26
-69
-74
-71
EBITDA
-2
-10
-18
-7
-44
-47
-44
Interest Expense
-
0
0
-
-
-
-
Depreciation
10
13
16
18
19
23
21
Income Before Tax
-13
-23
-34
-26
-64
-71
-66
Income Tax Expense
0
-6
-7
-3
-13
-9
-1
Net Income
-13
-17
-27
-22
-50
-62
-64
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
-18.17%

OmniAb Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-18
-13
-16
-13
-18
-15
-16
-14
-7
-5
Operating Cash Flow
-17
-12
-6
-3
-15
-5
-9
-5
-4
2
Investing Cash Flow
19
13
4
0
0
12
-7
2
8
-7
Financing Cash Flow
0
0
8
3
0
0
27
0
-
0
Change in Cash
2
1
6
0
-16
7
10
-3
3
-4

OmniAb Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-13
-17
-27
-22
-50
-62
-64
Operating Cash Flow
-5
3
-5
-3
2
-39
-36
Investing Cash Flow
-12
-26
-4
-73
-18
37
6
Financing Cash Flow
17
23
9
110
0
13
27
Change in Cash
-
-
-
33
-16
11
-2

Global Institutional Holdings in OmniAb

Check out the Institutions with significant holdings in OmniAb.

Funds
Holdings
iShares
3.87%
Vanguard
3.21%
VANGUARD INDEX FUNDS
2.68%
Delaware Group Equity Funds V
2.50%
Fidelity Salem Street Trust
0.84%
See all

OmniAb News & Key Events

  • img

    Today's Timeline - 06 October

    Tue, 05:50 PM

    -

    OmniAb hosts Investor Day, highlighting xPloration platform rollout and introducing OmniTides peptide discovery platform.

Insights on OmniAb

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, OABI stock has moved up by 116.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -16.52M → -5.85M (in $), with an average increase of 44.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 164.7% return, outperforming this stock by 171.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 561.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 14.4M → 13.41M (in $), with an average decrease of 6.8% per quarter

About OmniAb

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
OrganisationOmniAb
Headquarters5980 Horton Street, EmeryVille, CA, 94608, US
IndustryBiotechnology
CEOMatthew W. Foehr

Key Management of OmniAb

Name

Title

Mr. Matthew W. Foehr

President, CEO & Director

Mr. Kurt A. Gustafson

Executive VP of Finance & CFO

Mr. Charles S. Berkman J.D.

Chief Legal Officer

Mr. Amechi Nwachuku

Executive VP & Chief Operating Officer

Ms. Cia McCaffrey

Senior Vice President of People & Talent

Dr. Bill Harriman Ph.D.

Senior Vice President of Discovery Partnership Mgt., Technology Development & Operations

Dr. Bob Chen Ph.D.

Senior Vice President of Discovery Systems

Mr. Todd Pettingill C.F.A.

Vice President of Business Development & Strategy

Dr. Christel Iffland Ph.D.

Senior Vice President of R&D Portfolio Management and Technology Operations

Dr. Yasmina Noubia Abdiche Ph.D.

Senior Vice President of Exploratory Research

FAQs

What is OmniAb share price today?

OmniAb share price today is $4.70 as on at the close of the market. OmniAb share today touched a day high of $4.75 and a low of $4.53.

What is the 52 week high and 52 week low for OmniAb share?

OmniAb share touched a 52 week high of $5.43 on and a 52 week low of $1.30 on . OmniAb stock price today i.e. is closed at $4.70,which is 13.44% down from its 52 week high and 261.54% up from its 52 week low.

What is OmniAb's market capitalisation today?

OmniAb market capitalisation is $0.00T as on .

How to invest in OmniAb Stock (OABI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for OmniAb on INDmoney app. Click on Buy button.

What is the minimum amount required to buy OmniAb Stock (OABI) from India?

Indian investors can start investing in OmniAb (OABI) shares with as little as ₹94.91500091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.15 in OmniAb stock (as per the Rupee-Dollar exchange rate as on ). Based on OmniAb share’s latest price of $4.70 as on October 20, 2026 at 1:29 am IST, you will get 2.1277 shares of OmniAb. Learn more about fractional shares .